Market News
Stay updated with the latest market trends, earnings, and economic indicators.
IFCI Ltd leads losers in 'A' group
IDBI Bank Ltd, Inox India Ltd, Shilpa Medicare Ltd and Shaily Engineering Plastics Ltd are among the other losers in the BSE's 'A' group today, 18 June 2026.
Aurobindo Pharma Ltd leads losers in 'A' group
Ola Electric Mobility Ltd, Aster DM Healthcare Ltd, Data Patterns (India) Ltd and Shilpa Medicare Ltd are among the other losers in the BSE's 'A' group today, 15 June 2026.
Shilpa Biocare to acquire 30.4% stake in Barcelona-based Gate2Brain
Shilpa Medicare announced that its wholly owned subsidiary, Shilpa Biocare intends to make a strategic equity partnership of 30.4% in Gate2Brain. The investment of Euro 7 million includes cash infusion of Euro 0.5 million, equity for services Euro 5.5 million and Euro 1 million for development of project.
Shilpa Medicare to acquire 30.4% stake in Spain's Gate2Brain with €7 million investment
The global glioblastoma treatment market is estimated at approximately $3 billion in 2025 and is projected to exceed $6 billion by 2035. The pediatric brain tumour market is estimated at around $1.5 billion, while the market for DIPG therapies is expected to reach nearly $1.2 billion by 2035.
Shilpa Medicare Q4 results: Shares gain on sharp profit growth, exceptional gains boost earnings
Shilpa Medicare Q4FY26 profit surged to ₹108 crore on higher revenue and exceptional gains, FY26 earnings improved, dividend proposed. The company approved shifting its registered office from Karnataka to Maharashtra, subject to regulatory and shareholder approvals.
NCLT approves Shilpa Therapeutics’ amalgamation with Shilpa Medicare
Shares of Shilpa Medicare Ltd ended at ₹328.00, up by ₹12.15, or 3.85%, on the BSE.